MedTrace Logo

Population Pharmacokinetics, Effectiveness and Safety of Cefuroxime in Neonates

NCT05388747 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-05-24

No results posted yet for this study

Summary

Cefuroxime is a time-dependent antibiotic that is used to treat bacterial infections. However, population pharmacokinetic，effectiveness and safety data for cefuroxime in neonates are lacking. The aim of this study was to assess the population pharmacokinetics, effectiveness, and safety of cefuroxime in neonates.

Conditions

Interventions

DRUG

Cefuroxime

Population pharmacokinetics, effectiveness, and safety of cefuroxime

Sponsors & Collaborators

  • Tianjin Central Hospital of Gynecology Obstetrics

    collaborator OTHER

  • Shandong University

    lead OTHER

Eligibility

Min Age
0 Days
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-16
Primary Completion
2025-07-01
Completion
2025-12-01
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05388747 on ClinicalTrials.gov